Repare Therapeutics Shares Are Trading Higher After the Company Announced It Will Present Its Phase 1/2 Cancer Trial Data at the European Society of Medical Oncology Congress (ESMO).
Repare Therapeutics Shares Are Trading Higher After the Company Announced It Will Present Its Phase 1/2 Cancer Trial Data at the European Society of Medical Oncology Congress (ESMO).
Repare Therapeutics股價上漲，因該公司宣佈將在歐洲醫學腫瘤學會議（ESMO）上公佈其Phase 1/2癌症試驗數據。
Repare Therapeutics Shares Are Trading Higher After the Company Announced It Will Present Its Phase 1/2 Cancer Trial Data at the European Society of Medical Oncology Congress (ESMO).
Repare Therapeutics宣佈將在歐洲腫瘤內科學會大會（ESMO）上公佈其1/2期癌症試驗數據後，該公司股價走高。
資訊熱榜
更新時間